217 related articles for article (PubMed ID: 31260491)
1. The value of C-reactive protein as an independent prognostic indicator for disease-specific survival in patients with soft tissue sarcoma: A meta-analysis.
Wang X; Liu S; Zhao X; Fang E; Zhao X
PLoS One; 2019; 14(7):e0219215. PubMed ID: 31260491
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Role of Glasgow Prognostic Score and C-reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-Analysis.
Fang E; Wang X; Feng J; Zhao X
Dis Markers; 2020; 2020():8736509. PubMed ID: 31998420
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma.
Li Y; Liu X; Zhang J; Yao W
Cancer Biomark; 2016; 16(3):333-42. PubMed ID: 26835589
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of the serum level of C-reactive protein for the survival of patients with a primary sarcoma of bone.
Nakamura T; Grimer RJ; Gaston CL; Watanuki M; Sudo A; Jeys L
Bone Joint J; 2013 Mar; 95-B(3):411-8. PubMed ID: 23450030
[TBL] [Abstract][Full Text] [Related]
5. Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients.
Szkandera J; Gerger A; Liegl-Atzwanger B; Absenger G; Stotz M; Samonigg H; Maurer-Ertl W; Stojakovic T; Ploner F; Leithner A; Pichler M
Br J Cancer; 2013 Oct; 109(9):2316-22. PubMed ID: 24084772
[TBL] [Abstract][Full Text] [Related]
6. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma.
Park G; Song SY; Ahn JH; Kim WL; Lee JS; Jeong SY; Park JW; Choi EK; Choi W; Jung IH
Radiat Oncol; 2019 Jul; 14(1):116. PubMed ID: 31272506
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Factors for Predicting Survival in Soft-tissue Sarcoma with Metastatic Disease at Initial Presentation.
Nakamura T; Katagiri H; Shido Y; Hamada S; Yamada K; Nagano A; Yamada S; Tsukushi S; Ishimura D; Matsumine A; Sudo A; Nishida Y
Anticancer Res; 2017 Jun; 37(6):3137-3141. PubMed ID: 28551655
[TBL] [Abstract][Full Text] [Related]
9. Meta-Analysis of Hematological Biomarkers as Reliable Indicators of Soft Tissue Sarcoma Prognosis.
Li LQ; Bai ZH; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Wen J; Li JZ
Front Oncol; 2020; 10():30. PubMed ID: 32082998
[No Abstract] [Full Text] [Related]
10. Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis.
Dai J; Tang K; Xiao W; Yu G; Zeng J; Li W; Zhang YQ; Xu H; Chen ZQ; Ye ZQ
Asian Pac J Cancer Prev; 2014; 15(8):3369-75. PubMed ID: 24870724
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma.
Nakamura T; Matsumine A; Matsubara T; Asanuma K; Uchida A; Sudo A
Cancer; 2012 Feb; 118(4):1055-61. PubMed ID: 21761398
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of C-reactive protein/albumin ratio in nasopharyngeal carcinoma: a meta-analysis.
Gao N; Yang RN; Meng Z; Wang WH
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30352836
[TBL] [Abstract][Full Text] [Related]
13. Does the modified Glasgow Prognostic Score aid in the management of patients undergoing surgery for a soft-tissue sarcoma? : an international multicentre study.
Spence S; Doonan J; Farhan-Alanie OM; Chan CD; Tong D; Cho HS; Sahu MA; Traub F; Gupta S;
Bone Joint J; 2022 Jan; 104-B(1):168-176. PubMed ID: 34969280
[TBL] [Abstract][Full Text] [Related]
14. The role of C-reactive protein in predicting post-metastatic survival of patients with metastatic bone and soft tissue sarcoma.
Nakamura T; Matsumine A; Asanuma K; Matsubara T; Sudo A
Tumour Biol; 2015 Sep; 36(10):7515-20. PubMed ID: 25913621
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis.
Hu Q; Gou Y; Sun C; Ding W; Xu K; Gu B; Xia G; Ding Q
Urol Oncol; 2014 Jan; 32(1):50.e1-8. PubMed ID: 24239465
[TBL] [Abstract][Full Text] [Related]
16. The value of C-reactive protein and comorbidity in predicting survival of patients with high grade soft tissue sarcoma.
Nakamura T; Grimer R; Gaston C; Francis M; Charman J; Graunt P; Uchida A; Sudo A; Jeys L
Eur J Cancer; 2013 Jan; 49(2):377-85. PubMed ID: 23058786
[TBL] [Abstract][Full Text] [Related]
17. Preoperative C-reactive protein as a prognostic predictor for upper tract urothelial carcinoma: A systematic review and meta-analysis.
Luo Y; Fu SJ; She DL; Xiong HU; Yang LI
Mol Clin Oncol; 2015 Jul; 3(4):924-928. PubMed ID: 26171208
[TBL] [Abstract][Full Text] [Related]
18. Albumin-to-alkaline phosphatase ratio as a promising indicator of prognosis in human cancers: is it possible?
An L; Yin WT; Sun DW
BMC Cancer; 2021 Mar; 21(1):247. PubMed ID: 33685425
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in patients with soft tissue sarcoma: A meta-analysis.
Liu G; Ke LC; Sun SR
Medicine (Baltimore); 2018 Sep; 97(36):e12176. PubMed ID: 30200120
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Pretreated Blood Inflammatory Markers in Patients with Bone Sarcoma: A Meta-Analysis.
Jiang M; Ma S; Hua Z; Zhao Z; Gao S
Dis Markers; 2021; 2021():8839512. PubMed ID: 33897913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
